Lynette C. Daws - Publications

Affiliations: 
1994-1996 Physiology The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bowman MA, Daws LC. Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression. Frontiers in Neuroscience. 13: 156. PMID 30872996 DOI: 10.3389/fnins.2019.00156  0.68
2018 Gilman TL, Mitchell NC, Daws LC, Toney GM. Neuroinflammation contributes to high salt intake-augmented neuronal activation and active coping responses to acute stress. The International Journal of Neuropsychopharmacology. PMID 30535261 DOI: 10.1093/ijnp/pyy099  0.96
2018 Fraser-Spears R, Krause-Heuer AM, Basiouny M, Mayer FP, Manishimwe R, Wyatt NA, Dobrowolski JC, Roberts MP, Greguric I, Kumar N, Koek W, Sitte HH, Callaghan PD, Fraser BH, Daws LC. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. European Journal of Pharmacology. 842: 351-364. PMID 30473490 DOI: 10.1016/j.ejphar.2018.10.028  1
2018 Garbarino VR, Santos TA, Nelson AR, Zhang WQ, Smolik CM, Javors MA, Daws LC, Gould GG. Prenatal Metformin Exposure or Organic Cation Transporter 3 Knock-Out Curbs Social Interaction Preference in Male Mice. Pharmacological Research. PMID 30423430 DOI: 10.1016/j.phrs.2018.11.013  1
2018 Mayer FP, Schmid D, Holy M, Daws LC, Sitte HH. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux. Neurochemistry International. PMID 30248432 DOI: 10.1016/j.neuint.2018.09.008  0.32
2018 Garbarino VR, Gilman TL, Daws LC, Gould GG. Extreme Enhancement or Depletion of Serotonin Transporter Function and Serotonin Availability in Autism Spectrum Disorder. Pharmacological Research. PMID 30009933 DOI: 10.1016/j.phrs.2018.07.010  1
2018 Gilman TL, George CM, Vitela M, Herrera-Rosales M, Basiouny MS, Koek W, Daws LC. Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviors. The European Journal of Neuroscience. PMID 29797618 DOI: 10.1111/ejn.13968  0.44
2018 Mayer FP, Schmid D, Owens WA, Gould GG, Apuschkin M, Kudlacek O, Salzer I, Boehm S, Chiba P, Williams PH, Wu HH, Gether U, Koek W, Daws LC, Sitte HH. An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29773909 DOI: 10.1038/s41386-018-0053-5  1
2017 Koek W, Sandoval TL, Daws LC. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice. Behavioural Pharmacology. PMID 29200003 DOI: 10.1097/FBP.0000000000000371  1
2017 Koek W, Mitchell NC, Daws LC. Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice? Behavioural Pharmacology. PMID 29035921 DOI: 10.1097/FBP.0000000000000345  1
2017 Krause-Heuer AM, Fraser-Spears R, Dobrowolski JC, Ashford ME, Wyatt NA, Roberts MP, Gould GG, Cheah WC, Ng CKL, Bhadbhade M, Zhang B, Greguric I, Wheate NJ, Kumar N, Koek W, ... ... Daws LC, et al. Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22. European Journal of Medicinal Chemistry. 137: 476-487. PMID 28624702 DOI: 10.1016/j.ejmech.2017.06.011  1
2016 Sung U, Binda F, Savchenko V, Owens WA, Daws LC. Ca(2+) dependent surface trafficking of norepinephrine transporters depends on threonine 30 and Ca(2+) calmodulin kinases. Journal of Chemical Neuroanatomy. PMID 28017803 DOI: 10.1016/j.jchemneu.2016.12.003  0.56
2016 Mitchell NC, Bowman MA, Gould GG, Koek W, Daws LC. Ontogeny of NET expression and antidepressant-like response to desipramine in wild-type and SERT mutant mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27831486 DOI: 10.1124/jpet.116.237305  1
2016 Mitchell NC, Gould GG, Koek W, Daws LC. Ontogeny of SERT expression and antidepressant-like response to escitalopram in wild-type and SERT mutant mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27288483 DOI: 10.1124/jpet.116.233338  1
2015 Mitchell NC, Koek W, Daws LC. Antidepressant-like effects and basal immobility depend on age and serotonin transporter genotype. Genes, Brain, and Behavior. 14: 543-9. PMID 26250357 DOI: 10.1111/gbb.12238  1
2015 Baladi MG, Horton RE, Owens WA, Daws LC, France CP. Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18: pyv024. PMID 25805560 DOI: 10.1093/ijnp/pyv024  1
2015 Zhang WQ, Smolik CM, Barba-Escobedo PA, Gamez M, Sanchez JJ, Javors MA, Daws LC, Gould GG. Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology. 90: 1-8. PMID 25445490 DOI: 10.1016/j.neuropharm.2014.10.024  1
2014 Lamb RJ, Pinkston JW, Daws LC. Ethanol effects on multiple fixed-interval, fixed-ratio responding in mice with deletions of the serotonin transporter gene. Behavioural Pharmacology. 25: 92-5. PMID 24247279 DOI: 10.1097/FBP.0000000000000011  1
2014 Montañez S, Munn JL, Owens WA, Horton RE, Daws LC. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice. Neurochemistry International. 73: 127-31. PMID 24246466 DOI: 10.1016/j.neuint.2013.11.004  1
2013 Mitchell NC, Gould GG, Smolik CM, Koek W, Daws LC. Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function. Frontiers in Pharmacology. 4: 131. PMID 24191152 DOI: 10.3389/fphar.2013.00131  1
2013 Hensler JG, Artigas F, Bortolozzi A, Daws LC, De Deurwaerdère P, Milan L, Navailles S, Koek W. Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Advances in Pharmacology (San Diego, Calif.). 68: 167-97. PMID 24054145 DOI: 10.1016/B978-0-12-411512-5.00009-9  1
2013 Lamb RJ, Daws LC. Ethanol self-administration in serotonin transporter knockout mice: unconstrained demand and elasticity. Genes, Brain, and Behavior. 12: 741-7. PMID 23927813 DOI: 10.1111/gbb.12068  1
2013 Rickhag M, Owens WA, Winkler MT, Strandfelt KN, Rathje M, Sørensen G, Andresen B, Madsen KL, Jørgensen TN, Wörtwein G, Woldbye DP, Sitte H, Daws LC, Gether U. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. The Journal of Biological Chemistry. 288: 27534-44. PMID 23884410 DOI: 10.1074/jbc.M112.441295  1
2013 Horton RE, Apple DM, Owens WA, Baganz NL, Cano S, Mitchell NC, Vitela M, Gould GG, Koek W, Daws LC. Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 10534-43. PMID 23785165 DOI: 10.1523/JNEUROSCI.5687-11.2013  1
2013 Garcia-Olivares J, Torres-Salazar D, Owens WA, Baust T, Siderovski DP, Amara SG, Zhu J, Daws LC, Torres GE. Inhibition of dopamine transporter activity by G protein βγ subunits. Plos One. 8: e59788. PMID 23555781 DOI: 10.1371/journal.pone.0059788  1
2013 Daws LC, Koek W, Mitchell NC. Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders. Acs Chemical Neuroscience. 4: 16-21. PMID 23336039 DOI: 10.1021/cn3001872  1
2013 Andrews AM, Daws LC. What's old is new. Acs Chemical Neuroscience. 4: 1-2. PMID 23336035 DOI: 10.1021/cn300229z  1
2013 Daws LC, Koek W. Unfaithful Neurotransmitter Transporters: Focus on Biogenic Amine Reuptake and Implications for Antidepressant Efficacy Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 250. DOI: 10.1016/B978-0-12-800044-1.00220-8  1
2012 Baladi MG, Daws LC, France CP. You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology. 63: 76-86. PMID 22710441 DOI: 10.1016/j.neuropharm.2012.02.005  1
2012 Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, ... ... Daws LC, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences of the United States of America. 109: 5469-74. PMID 22431635 DOI: 10.1073/pnas.1112345109  1
2012 Owens WA, Williams JM, Saunders C, Avison MJ, Galli A, Daws LC. Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2637-47. PMID 22357848 DOI: 10.1523/JNEUROSCI.3759-11.2012  1
2011 Speed N, Saunders C, Davis AR, Owens WA, Matthies HJ, Saadat S, Kennedy JP, Vaughan RA, Neve RL, Lindsley CW, Russo SJ, Daws LC, Niswender KD, Galli A. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. Plos One. 6: e25169. PMID 21969871 DOI: 10.1371/journal.pone.0025169  1
2011 Daws LC, Gould GG. Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacology & Therapeutics. 131: 61-79. PMID 21447358 DOI: 10.1016/j.pharmthera.2011.03.013  1
2011 Daws LC, Avison MJ, Robertson SD, Niswender KD, Galli A, Saunders C. Insulin signaling and addiction. Neuropharmacology. 61: 1123-8. PMID 21420985 DOI: 10.1016/j.neuropharm.2011.02.028  1
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proceedings of the National Academy of Sciences of the United States of America. 108: 3785-90. PMID 21282638 DOI: 10.1073/pnas.1011920108  1
2011 Niswender KD, Daws LC, Avison MJ, Galli A. Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 359-60. PMID 21116253 DOI: 10.1038/npp.2010.167  1
2011 Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. Journal of Neurochemistry. 116: 291-303. PMID 21070242 DOI: 10.1111/j.1471-4159.2010.07104.x  1
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 9, (3785-3790) DOI: 10.1073/pnas.1011920108) Proceedings of the National Academy of Sciences of the United States of America. 108: 6689. DOI: 10.1073/pnas.1104147108  1
2010 Baganz N, Horton R, Martin K, Holmes A, Daws LC. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15185-95. PMID 21068324 DOI: 10.1523/JNEUROSCI.2740-10.2010  1
2010 Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2510-20. PMID 20827273 DOI: 10.1038/npp.2010.116  1
2010 Robertson SD, Matthies HJ, Owens WA, Sathananthan V, Christianson NS, Kennedy JP, Lindsley CW, Daws LC, Galli A. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11305-16. PMID 20739551 DOI: 10.1523/JNEUROSCI.0126-10.2010  1
2010 Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. Plos Biology. 8: e1000393. PMID 20543991 DOI: 10.1371/journal.pbio.1000393  1
2009 France CP, Li JX, Owens WA, Koek W, Toney GM, Daws LC. Reduced effectiveness of escitalopram in the forced swimming test is associated with increased serotonin clearance rate in food-restricted rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 731-6. PMID 19419596 DOI: 10.1017/S1461145709000418  1
2009 Daws LC. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacology & Therapeutics. 121: 89-99. PMID 19022290 DOI: 10.1016/j.pharmthera.2008.10.004  1
2008 Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 18976-81. PMID 19033200 DOI: 10.1073/pnas.0800466105  1
2008 Sevak RJ, Koek W, Owens WA, Galli A, Daws LC, France CP. Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. European Journal of Pharmacology. 592: 109-15. PMID 18652823 DOI: 10.1016/j.ejphar.2008.07.002  1
2008 Sevak RJ, Koek W, Daws LC, Owens WA, Galli A, France CP. Behavioral effects of amphetamine in streptozotocin-treated rats. European Journal of Pharmacology. 581: 105-12. PMID 18155695 DOI: 10.1016/j.ejphar.2007.11.047  1
2008 Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Molecular Psychiatry. 13: 631-40. PMID 17684498 DOI: 10.1038/sj.mp.4002056  1
2007 Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. Plos Biology. 5: e274. PMID 17941718 DOI: 10.1371/journal.pbio.0050274  1
2007 Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD. Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. The Journal of Pharmacology and Experimental Therapeutics. 322: 332-40. PMID 17460150 DOI: 10.1124/jpet.107.121665  1
2007 Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG. Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. Journal of Neurochemistry. 101: 641-51. PMID 17254018 DOI: 10.1111/j.1471-4159.2006.04392.x  1
2007 Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. Journal of Neurochemistry. 101: 389-96. PMID 17250681 DOI: 10.1111/j.1471-4159.2006.04383.x  1
2007 Sevak RJ, Owens WA, Koek W, Galli A, Daws LC, France CP. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. Journal of Neurochemistry. 101: 151-9. PMID 17217413 DOI: 10.1111/j.1471-4159.2006.04358.x  1
2007 Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function. Journal of Neurochemistry. 100: 617-27. PMID 17181558 DOI: 10.1111/j.1471-4159.2006.04247.x  1
2006 Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, Daws LC, Holmes A. Ethanol-related behaviors in serotonin transporter knockout mice. Alcoholism, Clinical and Experimental Research. 30: 1957-65. PMID 17117959 DOI: 10.1111/j.1530-0277.2006.00241.x  1
2006 Toney GM, Daws LC. Juxtacellular labeling and chemical phenotyping of extracellularly recorded neurons in vivo. Methods in Molecular Biology (Clifton, N.J.). 337: 127-37. PMID 16929944 DOI: 10.1385/1-59745-095-2:127  1
2006 Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. European Journal of Pharmacology. 546: 74-81. PMID 16925993 DOI: 10.1016/j.ejphar.2006.07.011  1
2006 Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron. 51: 417-29. PMID 16908408 DOI: 10.1016/j.neuron.2006.06.028  1
2006 Daws LC, Montañez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6431-8. PMID 16775130 DOI: 10.1523/JNEUROSCI.4050-05.2006  1
2005 Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, Galli A, France CP, Daws LC. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. Journal of Neurochemistry. 94: 1402-10. PMID 15992364 DOI: 10.1111/j.1471-4159.2005.03289.x  1
2005 Callaghan PD, Irvine RJ, Daws LC. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochemistry International. 47: 350-61. PMID 15979209 DOI: 10.1016/j.neuint.2005.04.026  1
2005 Daws LC, Montañez S, Owens WA, Gould GG, Frazer A, Toney GM, Gerhardt GA. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. Journal of Neuroscience Methods. 143: 49-62. PMID 15763136 DOI: 10.1016/j.jneumeth.2004.09.011  1
2003 Cowley C, Daws L, Ellis B. Health informatics and modernisation: Bridging the gap Informatics in Primary Care. 11: 207-214. PMID 14980060  1
2003 Montañez S, Daws LC, Gould GG, Frazer A. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. Journal of Neurochemistry. 87: 861-7. PMID 14622117 DOI: 10.1046/j.1471-4159.2003.02032.x  1
2003 Montañez S, Owens WA, Gould GG, Murphy DL, Daws LC. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. Journal of Neurochemistry. 86: 210-9. PMID 12807440 DOI: 10.1046/j.1471-4159.2003.01836.x  1
2003 Ansah TA, Ramamoorthy S, Montañez S, Daws LC, Blakely RD. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). The Journal of Pharmacology and Experimental Therapeutics. 305: 956-65. PMID 12626658 DOI: 10.1124/jpet.102.047134  1
2003 Overstreet DH, Daws LC, Yadid G, Friedman E, Mathé AA, Janowsky DS. Comment on "preclinical models: status of basic research in depression". Biological Psychiatry. 53: 268-70; author reply. PMID 12559663 DOI: 10.1016/S0006-3223(02)01869-3  1
2002 Montañez S, Daws LC, Gould GG, Gerhardt GA, Frazer A. Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Research. 955: 236-44. PMID 12419542 DOI: 10.1016/S0006-8993(02)03470-4  1
2002 Daws LC, Callaghan PD, Morón JA, Kahlig KM, Shippenberg TS, Javitch JA, Galli A. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochemical and Biophysical Research Communications. 290: 1545-50. PMID 11820798 DOI: 10.1006/bbrc.2002.6384  1
2000 Daws LC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F. Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 955-77. PMID 11041537 DOI: 10.1016/S0278-5846(00)00113-5  1
2000 Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. Journal of Neurochemistry. 75: 2113-22. PMID 11032901 DOI: 10.1046/j.1471-4159.2000.0752113.x  1
1999 Daws LC, White JM. Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification. Addiction Biology. 4: 391-7. PMID 20575807 DOI: 10.1080/13556219971371  1
1999 Frazer A, Gerhardt GA, Daws LC. New views of biogenic amine transporter function: implications for neuropsychopharmacology. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 305-320. PMID 11285147 DOI: 10.1017/S1461145799001625  1
1999 Daws LC, Gerhardt GA, Frazer A. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus. Neuroscience Letters. 266: 165-8. PMID 10465699 DOI: 10.1016/S0304-3940(99)00277-3  1
1999 Daws LC, Overstreet DH. Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat. Pharmacology, Biochemistry, and Behavior. 62: 367-80. PMID 9972706 DOI: 10.1016/S0091-3057(98)00174-9  1
1998 Frazer A, Daws LC. Serotonin transporter function in vivo: assessment by chronoamperometry. Annals of the New York Academy of Sciences. 861: 217-29. PMID 9928259 DOI: 10.1111/j.1749-6632.1998.tb10193.x  1
1998 Daws LC, Lopez R, Frazer A. Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoceptors in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 300-13. PMID 9718593 DOI: 10.1016/S0893-133X(98)00016-5  1
1998 Daws LC, Toney GM, Gerhardt GA, Frazer A. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. The Journal of Pharmacology and Experimental Therapeutics. 286: 967-76. PMID 9694957  1
1998 Overstreet DH, Daws LC, Schiller GD, Orbach J, Janowsky DS. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacology, Biochemistry, and Behavior. 59: 777-85. PMID 9586831 DOI: 10.1016/S0091-3057(97)00514-5  1
1997 Daws LC, Toney GM, Davis DJ, Gerhardt GA, Frazer A. In vivo chronoamperometric measurements of the clearance of exogenously applied serotonin in the rat dentate gyrus. Journal of Neuroscience Methods. 78: 139-50. PMID 9497010 DOI: 10.1016/S0165-0270(97)00144-1  1
1991 Daws LC, Schiller GD, Overstreet DH, Orbach J. Early development of muscarinic supersensitivity in a genetic animal model of depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 4: 207-17. PMID 2064720  1
1991 Schiller GD, Daws LC, Overstreet DH, Orbach J. Lack of anxiety in an animal model of depression with cholinergic supersensitivity. Brain Research Bulletin. 26: 433-5. PMID 2049612 DOI: 10.1016/0361-9230(91)90019-G  1
Show low-probability matches.